pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

STAT chooses to keep health care as two words despite AP stylebook shift

Jun 9, 2026·read at STAT ↗Neutral

The Associated Press updated its style guide in April, merging health care into the single word healthcare. The change sparked discussion among journalists and readers.

At STAT, the editorial staff, led by director Sarah Mupo, opened a dialogue with colleagues and asked readers for feedback on the spelling.

After reviewing the input, STAT decided to continue using the two-word form health care, saying it highlights the separate ideas of health and the care provided and reflects the variety of care services.

The outlet noted that while some terms naturally evolve into compounds, it views health care as an exception and will keep the traditional spelling for the foreseeable future.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Why STAT is sticking with ‘health care’ as two words”

read at STAT ↗
1,320 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Gossamer Bio, Inc.
topics
Psychiatry & CNS3CardiologyGene Therapy (AAV)Vaccines

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 24International childhood vaccine campaign growsSTAT
  • Jul 9STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugsSTAT
  • Jul 9STAT+: Prime wins Beam arbitration, clearing path to clinicSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT